Complete inhibition of allergic airway inflammation and remodelling in quadruple IL‐4/5/9/13−/− mice
- 28 August 2007
- journal article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 37 (10) , 1427-1435
- https://doi.org/10.1111/j.1365-2222.2007.02789.x
Abstract
Background T‐helper type 2 (Th2)‐derived cytokines such as IL‐4, IL‐5, IL‐9 and IL‐13 play an important role in the synthesis of IgE and in the promotion of allergic eosinophilic inflammation and airway wall remodelling. Objective We determined the importance of IL‐13 alone, and of the four Th2 cytokines together, by studying mice in which either IL‐13 alone or the Th2 cytokine cluster was genetically disrupted. Methods The knock‐out mice and their BALB/c wild‐type (wt) counterparts were sensitized and repeatedly exposed to ovalbumin (OVA) aerosol. Results Bronchial responsiveness measured as the concentration of acetylcholine aerosol needed to increase baseline lung resistance by 100% (PC100) was decreased in IL‐13−/−, but increased in IL‐4/5/9/13−/− mice. Chronic allergen exposure resulted in airway hyperresponsiveness (AHR) in wt mice but not in both genetically modified mice. After allergen exposure, eosinophil counts in bronchoalveolar lavage fluid and in airways mucosa, and goblet cell numbers were not increased in IL‐4/5/9/13−/− mice, and were only attenuated in IL‐13−/− mice. Airway smooth muscle (ASM) hyperplasia after allergen exposure was prevented in both IL‐13−/− and IL‐4/5/9/13−/− mice to an equal extent. Similarly, the rise in total or OVA‐specific serum IgE levels was totally inhibited. Conclusion IL‐13 is mainly responsible for AHR, ASM hyperplasia and increases in IgE, while IL‐4, ‐5 and ‐9 may contribute to goblet cell hyperplasia and eosinophilic inflammation induced by chronic allergen exposure in a murine model. Both redundancy or complementariness of Th2 cytokines can occur in vivo, according to specific aspects of the allergic response.Keywords
This publication has 36 references indexed in Scilit:
- IL-13 may mediate allergen-induced hyperresponsiveness independently of IL-5 or eotaxin by effects on airway smooth muscleAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Role of interleukin‐13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthmaClinical and Experimental Allergy, 2002
- The Absence of Interleukin 9 Does Not Affect the Development of Allergen-induced Pulmonary Inflammation nor Airway HyperreactivityThe Journal of Experimental Medicine, 2002
- Cytokines in asthmaEuropean Respiratory Journal, 2001
- IL-9-Deficient Mice Establish Fundamental Roles for IL-9 in Pulmonary Mastocytosis and Goblet Cell Hyperplasia but Not T Cell DevelopmentImmunity, 2000
- Cytokines in asthmaThorax, 1999
- Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia.Journal of Clinical Investigation, 1998
- Effect of antigen provocation of IL-5 transgenic mice on eosinophil mobilization and bronchial hyperresponsivenessJournal of Allergy and Clinical Immunology, 1996
- Interleukin‐9 potentiates the interleukin‐4‐induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytesEuropean Journal of Immunology, 1993
- Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor.The Journal of Experimental Medicine, 1988